UBS Share Price Is Down 9% This Year — and Switzerland Just Made the Next Few Years Considerably More Complicated

A revised Capital Adequacy Ordinance was released by the Swiss Federal Council early on April 22 and landed with a thud on UBS’s balance sheet. The new regulations, which go into effect on January 1, 2027, would require UBS to hold an additional $22 billion in CET1 capital. This amount would come from a proposed parliamentary measure that would require the full deduction of foreign participations from UBS AG’s standalone capital, as well as $2 billion from ordinance amendments covering software amortization and asset valuation. In a prompt and non-diplomatic response, the bank stated that it “continues to strongly disagree” with the proposed package, citing its potential far-reaching effects on the Swiss economy as well as its lack of international alignment. The Swiss finance minister swiftly clarified that UBS would still be able to pay dividends during the implementation period, seemingly aware of how this would appear. At CHF 33.54, the stock hardly moved.

This regulation’s background is important. The arrangement was portrayed as a necessary rescue—a controlled implosion that prevented something much worse—when Credit Suisse collapsed in the spring of 2023 and the Swiss government orchestrated an emergency takeover by UBS. However, it also produced something Switzerland had never had before: a single bank so big in relation to the country’s economy that, in the strictest sense, its failure would constitute a national crisis. It was obvious that the regulatory framework in place for Credit Suisse had not been adequate. It makes sense to write new regulations after that realization. The fact that the organization being asked to hold more capital is the same one that was forced to take over Credit Suisse in the first place and already has about $15 billion in additional capital requirements from that acquisition makes matters more complicated.

IMPORTANT INFORMATION — UBS GROUP AG (SWX: UBSG)

It is worthwhile to sit with the cumulative figures. The new capital will have an annual carrying cost of about $3 billion. a de facto minimum CET1 ratio that is close to 18.4 percent, which is significantly higher than what peers in other countries must maintain. The regulatory package could result in cumulative losses to Switzerland’s GDP of up to CHF 34 billion over a ten-year period, according to BAK Economics, which was hired to analyze the effects. A marginal footnote is not what that is. The finance minister’s statement that there is “no reason for UBS to leave Switzerland” indicates that the possibility is being taken seriously enough to necessitate public assurance, and it represents a significant national economic cost.

UBS has maintained its commitment to 2026 capital returns, and CEO Sergio Ermotti has insisted that the bank will attain an underlying return on CET1 capital of roughly 15% by the end of 2026. Under the new regulatory math, that goal is not simple; it calls for making enough money to cover integration costs from the Credit Suisse merger while also achieving a significant return on a very large capital base. The market will be watching whether the underlying business momentum—wealth management inflows, investment banking revenues, and the advancement of Credit Suisse integration—is strong enough to support that target despite the growing regulatory obstacles when the Q1 2026 earnings are due on April 30.

While American banks have generally done better, it is difficult to ignore the fact that UBS’s share price has dropped 9% year to date. JPMorgan, Goldman Sachs, and Morgan Stanley have all encountered difficulties, but none of them have the particular regulatory burden that a universal bank with Swiss headquarters currently bears. With an average target of CHF 37.71, the analyst consensus is still Outperform, suggesting an increase of about 12% from current levels. On April 22, RBC kept its Buy rating. Barclays is in a neutral position. The capital rules introduce a variable that wasn’t fully priced in at the beginning of the year and won’t be fully resolved until parliament acts, giving the impression that the investment case is intact in theory but complicated in practice.

Observing UBS navigate this moment—managing the biggest private bank in the world, completing one of the most intricate financial acquisitions in history, and concurrently disputing capital requirements with its home government—is like witnessing an organization attempting to carry out multiple tasks simultaneously, not all of which are moving in the same direction. One indicator of how well that’s going will be the earnings call on April 30. The other will be the regulatory timeline.